Get the Stockscreener App
1.17
1.74%
0.02
After Hours:
1.16
-0.01
-0.85%
Boundless Bio Inc stock is traded at $1.17, with a volume of 45,900.
It is up +1.74% in the last 24 hours and down -4.88% over the past month.
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.
See More
Previous Close:
$1.15
Open:
$1.1756
24h Volume:
45,900
Relative Volume:
0.31
Market Cap:
$26.19M
Revenue:
-
Net Income/Loss:
$-64.39M
P/E Ratio:
-0.4052
EPS:
-2.8877
Net Cash Flow:
$-56.24M
1W Performance:
+2.63%
1M Performance:
-4.88%
6M Performance:
+7.34%
1Y Performance:
-60.34%
1-Day Range:
$1.16
$1.18
1-Week Range:
$1.11
$1.20
52-Week Range:
$1.00
$3.12
Boundless Bio Inc Stock (BOLD) Company Profile
Name
Boundless Bio Inc
Sector
Industry
Phone
(858) 766-9912
Address
10955 ALEXANDRIA WAY, SAN DIEGO
Compare BOLD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BOLD
Boundless Bio Inc
|
1.17 | 25.74M | 0 | -64.39M | -56.24M | -2.8877 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Boundless Bio Inc Stock (BOLD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Initiated | H.C. Wainwright | Buy |
| May-28-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-13-24 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-22-24 | Initiated | Guggenheim | Buy |
| Apr-22-24 | Initiated | Leerink Partners | Outperform |
| Apr-22-24 | Initiated | Piper Sandler | Overweight |
View All
Boundless Bio Inc Stock (BOLD) Latest News
Chipmakers Recap: Why ON Semiconductor Corporation stock is seen as undervaluedWeekly Trend Report & Free Risk Controlled Daily Trade Plans - moha.gov.vn
Can Elgi Equipments Limited Achieve Revenue Diversification SuccessfullySector Leadership Analysis & Discover Stocks Experts Are Watching - earlytimes.in
Boundless Bio Inc Stock Analysis and ForecastRisk-Reward Ratio Analysis & Ride the Wave of Market-Beating Growth - earlytimes.in
Taking on analysts’ expectations and winning: Sociedad Quimica Y Minera de Chile S.A. ADR (SQM) - setenews.com
BOLD: Advancing novel ecDNA-targeted therapies, with BBI-940 entering clinical trials in 1H 2026 - TradingView
Checkpoint Inhibitors Pipeline & Competitive Landscape Report 2025 - openPR.com
Hedge Fund Bets: Can Rein Therapeutics Inc stock attract ESG capital inflowsJuly 2025 Price Swings & Daily Price Action Insights - BỘ NỘI VỤ
Get in on Boundless Bio Inc’s (BOLD) buy-in window today! - setenews.com
Stocks of Petco Health and Wellness Co Inc (WOOF) are poised to climb above their peers - setenews.com
Adversity is less terrifying than hope: ALT5 Sigma Corp (ALTS) - Setenews
Boundless Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference - The Manila Times
Boundless Bio (Nasdaq: BOLD) in Fireside Chat at Piper Sandler Conference - Stock Titan
Will Boundless Bio Inc. stock benefit from infrastructure spendingJuly 2025 Drop Watch & Daily Profit Focused Stock Screening - newser.com
Is Boundless Bio Inc. a candidate for recovery playGDP Growth & Reliable Momentum Entry Alerts - newser.com
Will earnings trigger a reversal in Boundless Bio Inc.Weekly Trend Recap & Technical Analysis for Trade Confirmation - newser.com
Detecting support and resistance levels for Boundless Bio Inc.July 2025 WrapUp & Expert Curated Trade Setup Alerts - newser.com
What analyst consensus says on Boundless Bio Inc. stock2025 Buyback Activity & Weekly Stock Breakout Alerts - newser.com
How to monitor Boundless Bio Inc. with trend dashboardsSell Signal & Capital Efficiency Focused Ideas - newser.com
Will Boundless Bio Inc. bounce back from current supportMarket Movers & Verified Technical Signals - newser.com
Can Boundless Bio Inc. stock sustain institutional interestJuly 2025 Decliners & Free Daily Entry Point Trade Alerts - newser.com
Volatility clustering patterns for Boundless Bio Inc.Market Sentiment Report & Community Trade Idea Sharing Platform - newser.com
Boundless Bio Inc. stock trend outlook and recovery pathShort Setup & Weekly High Conviction Trade Ideas - newser.com
Market reaction to Boundless Bio Inc.’s recent newsJuly 2025 Summary & Weekly Stock Performance Updates - newser.com
How to build a custom watchlist for Boundless Bio Inc.Weekly Trade Review & Daily Chart Pattern Signals - newser.com
Is this a good reentry point in Boundless Bio Inc.Earnings Beat & AI Enhanced Execution Alerts - newser.com
How Boundless Bio Inc. stock valuations compare to rivalsSell Signal & Weekly Return Optimization Alerts - newser.com
Is Boundless Bio Inc. stock a buy for dividend growthWeekly Profit Report & Fast Gaining Stock Reports - newser.com
Can Boundless Bio Inc. stock outperform in 2025 bull market - newser.com
Published on: 2025-11-06 12:44:37 - newser.com
Is Boundless Bio Inc. stock positioned for digital transformation2025 Earnings Impact & Technical Pattern Recognition Alerts - newser.com
Is Boundless Bio Inc. stock a top pick in earnings seasonTake Profit & Fast Gain Swing Alerts - fcp.pa.gov.br
Inflammation biotech Evommune heads to NYSE with $150M IPO - Fierce Biotech
Boundless Bio Inc Stock (BOLD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):